{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:38:12Z","timestamp":1794537492017,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300372"],"award-info":[{"award-number":["82300372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Cardiovascular Health Alliance-Access Research Fund","award":["2021-CCA-ACCESS-130"],"award-info":[{"award-number":["2021-CCA-ACCESS-130"]}]},{"name":"Program for Youth Innovation in Future Medicine, Chongqing Medical University","award":["03030204QC-W0186"],"award-info":[{"award-number":["03030204QC-W0186"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05030-x","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:43:56Z","timestamp":1758627836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of epicardial adipose tissue volume and hypertension on left ventricular hypertrophy in preclinical heart failure patients with metabolic syndrome"],"prefix":"10.1186","volume":"25","author":[{"given":"Junshi","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"1","key":"5030_CR1","doi-asserted-by":"publisher","first-page":"2405080","DOI":"10.1080\/07853890.2024.2405080","volume":"56","author":"Y Han","year":"2024","unstructured":"Han Y, Li Y, Wu Z, et al. Progress in diagnosis and treatment of hypertension combined with left ventricular hypertrophy. Ann Med Dec. 2024;56(1):2405080. https:\/\/doi.org\/10.1080\/07853890.2024.2405080.","journal-title":"Ann Med Dec"},{"issue":"24","key":"5030_CR2","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1097\/cm9.0000000000003431","volume":"20","author":"Clinical practice guideline for the management of hypertension in China","year":"2024","unstructured":"Clinical practice guideline for the management of hypertension in China. Chin Med J (Engl) Dec. 2024;20(24):2907\u201352. https:\/\/doi.org\/10.1097\/cm9.0000000000003431.","journal-title":"Chin Med J (Engl) Dec"},{"key":"5030_CR3","doi-asserted-by":"publisher","first-page":"7890188","DOI":"10.1155\/2023\/7890188","volume":"2023","author":"H Ahmad","year":"2023","unstructured":"Ahmad H, Khan H, Haque S, Ahmad S, Srivastava N, Khan A. Angiotensin-Converting enzyme and hypertension: A systemic analysis of various ACE inhibitors, their side effects, and bioactive peptides as a putative therapy for hypertension. J Renin Angiotensin Aldosterone Syst. 2023;2023:7890188. https:\/\/doi.org\/10.1155\/2023\/7890188.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"5","key":"5030_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/00015385.2019.1598638","volume":"75","author":"T Di Chiara","year":"2020","unstructured":"Di Chiara T, Tuttolomondo A, Parrinello G, Colomba D, Pinto A, Scaglione R. Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities. Acta Cardiol Sep. 2020;75(5):413\u201320. https:\/\/doi.org\/10.1080\/00015385.2019.1598638.","journal-title":"Acta Cardiol Sep"},{"key":"5030_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1475-2840-10-29","volume":"14","author":"JB Somaratne","year":"2011","unstructured":"Somaratne JB, Whalley GA, Poppe KK, et al. Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. Cardiovasc Diabetol Apr. 2011;14:10:29. https:\/\/doi.org\/10.1186\/1475-2840-10-29.","journal-title":"Cardiovasc Diabetol Apr"},{"issue":"9","key":"5030_CR6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/echo.13247","volume":"33","author":"MM Al-Daydamony","year":"2016","unstructured":"Al-Daydamony MM, El-Tahlawi M. What is the effect of metabolic syndrome without hypertension on left ventricular hypertrophy?? Echocardiography Sep. 2016;33(9):1284\u20139. https:\/\/doi.org\/10.1111\/echo.13247.","journal-title":"Echocardiography Sep"},{"issue":"41","key":"5030_CR7","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1093\/eurheartj\/ehz203","volume":"1","author":"M Mohan","year":"2019","unstructured":"Mohan M, Al-Talabany S, McKinnie A, et al. A randomized controlled trial of Metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial. Eur Heart J Nov. 2019;1(41):3409\u201317. https:\/\/doi.org\/10.1093\/eurheartj\/ehz203.","journal-title":"Eur Heart J Nov"},{"issue":"6","key":"5030_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/circulationaha.120.052186","volume":"9","author":"MMY Lee","year":"2021","unstructured":"Lee MMY, Brooksbank KJM, Wetherall K, et al. Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation Feb. 2021;9(6):516\u201325. https:\/\/doi.org\/10.1161\/circulationaha.120.052186.","journal-title":"Circulation Feb"},{"issue":"6","key":"5030_CR9","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1111\/dom.15557","volume":"26","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yang D, Jia Q, Yan J, An F. The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: an updated systematic review and meta-analysis. Diabetes Obes Metab Jun. 2024;26(6):2401\u201311. https:\/\/doi.org\/10.1111\/dom.15557.","journal-title":"Diabetes Obes Metab Jun"},{"issue":"3","key":"5030_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ajh.2009.253","volume":"23","author":"Y Iwashima","year":"2010","unstructured":"Iwashima Y, Horio T, Kamide K, et al. Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension. Am J Hypertens Mar. 2010;23(3):290\u20138. https:\/\/doi.org\/10.1038\/ajh.2009.253.","journal-title":"Am J Hypertens Mar"},{"issue":"1","key":"5030_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","volume":"17","author":"IJ Neeland","year":"2024","unstructured":"Neeland IJ, Lim S, Tchernof A, et al. Metabolic syndrome. Nat Rev Dis Primers Oct. 2024;17(1):77. https:\/\/doi.org\/10.1038\/s41572-024-00563-5.","journal-title":"Nat Rev Dis Primers Oct"},{"key":"5030_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1265\/ehpm.24-00154","volume":"30","author":"B Lin","year":"2025","unstructured":"Lin B, Hu Y, He H, et al. Regional adipose distribution and metabolically unhealthy phenotype in Chinese adults: evidence from China National health survey. Environ Health Prev Med. 2025;30:5. https:\/\/doi.org\/10.1265\/ehpm.24-00154.","journal-title":"Environ Health Prev Med"},{"issue":"10","key":"5030_CR13","doi-asserted-by":"publisher","first-page":"e0293017","DOI":"10.1371\/journal.pone.0293017","volume":"18","author":"B Huang","year":"2023","unstructured":"Huang B, DePaolo J, Judy RL, et al. Relationships between body fat distribution and metabolic syndrome traits and outcomes: A Mendelian randomization study. PLoS ONE. 2023;18(10):e0293017. https:\/\/doi.org\/10.1371\/journal.pone.0293017.","journal-title":"PLoS ONE"},{"issue":"5","key":"5030_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/heartjnl-2020-318242","volume":"108","author":"SL Ayton","year":"2022","unstructured":"Ayton SL, Gulsin GS, McCann GP, Moss AJ. Epicardial adipose tissue in obesity-related cardiac dysfunction. Heart Mar. 2022;108(5):339\u201344. https:\/\/doi.org\/10.1136\/heartjnl-2020-318242.","journal-title":"Heart Mar"},{"issue":"1","key":"5030_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12933-023-01778-8","volume":"4","author":"J Liu","year":"2023","unstructured":"Liu J, Yu Q, Li Z, et al. Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study. Cardiovasc Diabetol Mar. 2023;4(1):45. https:\/\/doi.org\/10.1186\/s12933-023-01778-8.","journal-title":"Cardiovasc Diabetol Mar"},{"issue":"2","key":"5030_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3760\/cma.j.cn115624-20231201-00314","volume":"18","author":"Chinese Medical Association","year":"2024","unstructured":"Chinese Medical Association. Editorial board of Chinese journal of health Management; National clinical research center for geriatric disorders (Xiangya Hospital). Expert Consensus on health Education for the Prevention and Control of Metabolic Syndrome in Adults. Chin J Health Manage. 2024;18(2):81\u201392. https:\/\/doi.org\/10.3760\/cma.j.cn115624-20231201-00314.","journal-title":"Chin J Health Manage"},{"key":"5030_CR17","doi-asserted-by":"publisher","unstructured":"Ningling SZ, Yong S. Expert consensus on the diagnosis and treatment of hypertension. Zhong Hua Xin Xue Guan Bing Za Zhi. 2019;2. https:\/\/doi.org\/10.3760\/cmaj.issn.2096-1588.2019.1000025.","DOI":"10.3760\/cmaj.issn.2096-1588.2019.1000025"},{"issue":"9","key":"5030_CR18","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1097\/hjh.0000000000003774","volume":"1","author":"DB \u0110or\u0111evi\u0107","year":"2024","unstructured":"\u0110or\u0111evi\u0107 DB, Kora\u010devi\u0107 GP, \u0110or\u0111evi\u0107 AD, Lovi\u0107 DB. Hypertension and left ventricular hypertrophy. J Hypertens Sep. 2024;1(9):1505\u201315. https:\/\/doi.org\/10.1097\/hjh.0000000000003774.","journal-title":"J Hypertens Sep"},{"key":"5030_CR19","doi-asserted-by":"publisher","first-page":"1159973","DOI":"10.1155\/2023\/1159973","volume":"2023","author":"L Wang","year":"2023","unstructured":"Wang L, Song TT, Dong CW. Association between interactions among ACE gene polymorphisms and essential hypertension in patients in the Hefei region, anhui, China. J Renin Angiotensin Aldosterone Syst. 2023;2023:1159973. https:\/\/doi.org\/10.1155\/2023\/1159973.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"3","key":"5030_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12020-013-9883-4","volume":"43","author":"NY Li","year":"2013","unstructured":"Li NY, Yu J, Zhang XW, et al. Features of left ventricular hypertrophy in patients with metabolic syndrome with or without comparable blood pressure: a meta-analysis. Endocrine Jun. 2013;43(3):548\u201363. https:\/\/doi.org\/10.1007\/s12020-013-9883-4.","journal-title":"Endocrine Jun"},{"key":"5030_CR21","doi-asserted-by":"publisher","first-page":"1215527","DOI":"10.3389\/fendo.2023.1215527","volume":"14","author":"M Dro\u017cd\u017c","year":"2023","unstructured":"Dro\u017cd\u017c M, Moczulska A, Rudzi\u0144ski A, Dro\u017cd\u017c D. Metabolic syndrome as risk factor for left ventricular hypertrophy in children with chronic kidney disease. Front Endocrinol (Lausanne). 2023;14:1215527. https:\/\/doi.org\/10.3389\/fendo.2023.1215527.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5030_CR22","doi-asserted-by":"publisher","unstructured":"Xu R, Wang C, Cong H, Wang L. Association of metabolic phenotypes with cardiovascular events in patients aged 18\u201345 with acute coronary syndrome. Endocrine. 2025;10. https:\/\/doi.org\/10.1007\/s12020-025-04169-z.","DOI":"10.1007\/s12020-025-04169-z"},{"key":"5030_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","volume":"80","author":"C Borghi","year":"2020","unstructured":"Borghi C, Agabiti-Rosei E, Johnson RJ, et al. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur J Intern Med Oct. 2020;80:1\u201311. https:\/\/doi.org\/10.1016\/j.ejim.2020.07.006.","journal-title":"Eur J Intern Med Oct"},{"issue":"1","key":"5030_CR24","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/s41598-025-86497-8","volume":"17","author":"AA Salim","year":"2025","unstructured":"Salim AA, Kawasoe S, Kubozono T, et al. Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases. Sci Rep Jan. 2025;17(1):2319. https:\/\/doi.org\/10.1038\/s41598-025-86497-8.","journal-title":"Sci Rep Jan"},{"issue":"1","key":"5030_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12872-020-01350-2","volume":"3","author":"S Yu","year":"2020","unstructured":"Yu S, Chen Y, Yang H, Guo X, Zheng L, Sun Y. Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese. BMC Cardiovasc Disord Feb. 2020;3(1):44. https:\/\/doi.org\/10.1186\/s12872-020-01350-2.","journal-title":"BMC Cardiovasc Disord Feb"},{"issue":"1","key":"5030_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12944-024-02282-y","volume":"12","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhu Z, Shen J, et al. Predictive value of remnant cholesterol for left ventricular hypertrophy and prognosis in hypertensive patients with heart failure: a prospective study. Lipids Health Dis Sep. 2024;12(1):294. https:\/\/doi.org\/10.1186\/s12944-024-02282-y.","journal-title":"Lipids Health Dis Sep"},{"issue":"1","key":"5030_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1186\/s40001-024-02234-3","volume":"26","author":"M Jv","year":"2024","unstructured":"Jv M, Zhang J, Han Y, Yang A, Zhu Y. Association of triglyceride glucose-body mass index and left ventricular hypertrophy in patients with IgA nephropathy: a retrospective study. Eur J Med Res Dec. 2024;26(1):627. https:\/\/doi.org\/10.1186\/s40001-024-02234-3.","journal-title":"Eur J Med Res Dec"},{"issue":"2","key":"5030_CR28","doi-asserted-by":"publisher","first-page":"108947","DOI":"10.1016\/j.jdiacomp.2024.108947","volume":"39","author":"S Liu","year":"2025","unstructured":"Liu S, Ke J, Feng X, et al. Diabetic microvascular complications are associated with left ventricular hypertrophy in patients with type 2 diabetes mellitus. J Diabetes Complications Feb. 2025;39(2):108947. https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108947.","journal-title":"J Diabetes Complications Feb"},{"key":"5030_CR29","doi-asserted-by":"publisher","first-page":"1355968","DOI":"10.3389\/fendo.2025.1355968","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Yin G, Zhang Y, et al. Effect of fat distribution on left ventricular structure and function in different sexes: a Mendelian randomization study. Front Endocrinol (Lausanne). 2025;16:1355968. https:\/\/doi.org\/10.3389\/fendo.2025.1355968.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5030_CR30","doi-asserted-by":"publisher","first-page":"1465577","DOI":"10.3389\/fendo.2024.1465577","volume":"15","author":"W Wang","year":"2024","unstructured":"Wang W, Chen Y, Qiu XP, Guo XL. The association of perirenal adipose tissue accumulation with left ventricular hypertrophy and the mediating role of insulin resistance: a cross-sectional study involving 1112 individuals with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2024;15:1465577. https:\/\/doi.org\/10.3389\/fendo.2024.1465577.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"5030_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/mop.0000000000001209","volume":"1","author":"VC Giammattei","year":"2023","unstructured":"Giammattei VC, Weaver DJ Jr., South AM. Management of acute severe hypertension in youth: from the philosophical to the practical. Curr Opin Pediatr Apr. 2023;1(2):251\u20138. https:\/\/doi.org\/10.1097\/mop.0000000000001209.","journal-title":"Curr Opin Pediatr Apr"},{"issue":"3","key":"5030_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4093\/dmj.2023.0190","volume":"48","author":"DH Cho","year":"2024","unstructured":"Cho DH, Park SM. Epicardial adipose tissue and heart failure, friend or foe?? Diabetes Metab J May. 2024;48(3):373\u201384. https:\/\/doi.org\/10.4093\/dmj.2023.0190.","journal-title":"Diabetes Metab J May"},{"issue":"1","key":"5030_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1532-429x-12-40","volume":"12","author":"C Doesch","year":"2010","unstructured":"Doesch C, Haghi D, Fl\u00fcchter S, et al. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson Jul. 2010;12(1):40. https:\/\/doi.org\/10.1186\/1532-429x-12-40.","journal-title":"J Cardiovasc Magn Reson Jul"},{"issue":"10","key":"5030_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.acvd.2019.06.005","volume":"112","author":"D Arangalage","year":"2019","unstructured":"Arangalage D, Mathieu T, Nguyen V, et al. Epicardial adipose tissue volume is associated with left ventricular remodelling in calcific aortic valve stenosis. Arch Cardiovasc Dis Oct. 2019;112(10):594\u2013603. https:\/\/doi.org\/10.1016\/j.acvd.2019.06.005.","journal-title":"Arch Cardiovasc Dis Oct"},{"issue":"5","key":"5030_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.6515\/acs.202209_38(5).20220331b","volume":"38","author":"MC Yang","year":"2022","unstructured":"Yang MC, Liu HK, Tsai CC, Su YT, Wu JR. Epicardial adipose tissue was highly associated with reduction in left ventricular diastolic function as early as in adolescence. Acta Cardiol Sin Sep. 2022;38(5):601\u201311. https:\/\/doi.org\/10.6515\/acs.202209_38(5).20220331b.","journal-title":"Acta Cardiol Sin Sep"},{"issue":"1","key":"5030_CR36","doi-asserted-by":"publisher","first-page":"qyae056","DOI":"10.1093\/ehjimp\/qyae056","volume":"2","author":"H Ishikawa","year":"2024","unstructured":"Ishikawa H, Sugiyama T, Otsuka K, et al. Impact of epicardial adipose tissue on diastolic dysfunction in patients with chronic coronary syndrome and preserved left ventricular ejection fraction. Eur Heart J Imaging Methods Pract Jan. 2024;2(1):qyae056. https:\/\/doi.org\/10.1093\/ehjimp\/qyae056.","journal-title":"Eur Heart J Imaging Methods Pract Jan"},{"issue":"6","key":"5030_CR37","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1002\/mco2.413","volume":"4","author":"Y Song","year":"2023","unstructured":"Song Y, Tan Y, Deng M, et al. Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies. MedComm (2020). 2023;4(6). https:\/\/doi.org\/10.1002\/mco2.413.","journal-title":"MedComm (2020)."},{"issue":"12","key":"5030_CR38","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/ejhf.2741","volume":"24","author":"G van Woerden","year":"2022","unstructured":"van Woerden G, van Veldhuisen DJ, Westenbrink BD, de Boer RA, Rienstra M, Gorter TM. Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives. Eur J Heart Fail Dec. 2022;24(12):2238\u201350. https:\/\/doi.org\/10.1002\/ejhf.2741.","journal-title":"Eur J Heart Fail Dec"},{"issue":"2","key":"5030_CR39","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s00330-023-10081-9","volume":"34","author":"J Liu","year":"2024","unstructured":"Liu J, Qu Y, Li J, et al. Myocardial tissue remodeling in early adult obesity and its association with regional adipose tissue distribution and ectopic fat deposits: a prospective study. Eur Radiol Feb. 2024;34(2):970\u201380. https:\/\/doi.org\/10.1007\/s00330-023-10081-9.","journal-title":"Eur Radiol Feb"},{"issue":"9","key":"5030_CR40","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41419-021-04111-x","volume":"13","author":"S Hao","year":"2021","unstructured":"Hao S, Sui X, Wang J, et al. Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation. Cell Death Dis Sep. 2021;13(9):848. https:\/\/doi.org\/10.1038\/s41419-021-04111-x.","journal-title":"Cell Death Dis Sep"},{"issue":"5","key":"5030_CR41","doi-asserted-by":"publisher","first-page":"101559","DOI":"10.1016\/j.xcrm.2024.101559","volume":"21","author":"Y Fan","year":"2024","unstructured":"Fan Y, Huang S, Li S, et al. The adipose-neural axis is involved in epicardial adipose tissue-related cardiac arrhythmias. Cell Rep Med. May 2024;21(5):101559. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101559.","journal-title":"Cell Rep Med"},{"key":"5030_CR42","doi-asserted-by":"publisher","first-page":"e13912","DOI":"10.1111\/obr.13912","volume":"1","author":"Z Qi","year":"2025","unstructured":"Qi Z, Wu D, Yan Z, et al. Role of epicardial adipose tissue in heart failure with preserved ejection fraction: an emerging molecular mechanism and therapeutic potential. Obes Rev Mar. 2025;1:e13912. https:\/\/doi.org\/10.1111\/obr.13912.","journal-title":"Obes Rev Mar"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05030-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:24:50Z","timestamp":1758720290000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5030"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05030-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (Approval No. 2018-035). The requirement for informed consent was waived due to the retrospective nature of the analysis by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University. The study adhered to the Declaration of Helsinki ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"656"}}